SMU
NNVC icon

Signet Management USA’s NanoViricides NNVC Stock Holding History

Signet Management USA’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$3K Buy
+29
New +$2.98K ﹤0.01% 184

Other funds holding NNVC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.24B AUM 22.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $7.32B AUM 26.67% 1-Year Est. Return

Signet Management USA's NNVC Position: Q4 2013 in Review

Signet Management USA opened a new position in NanoViricides (NNVC) in Q4 2013: 29 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #184 among its holdings.

27 funds tracked by Wall St. Rank hold NNVC as of Q4 2013.

  • Signet Management USA held 29 shares of NanoViricides worth $3K as of Q4 2013.
  • NanoViricides was a new Signet Management USA position in Q4 2013.
  • NanoViricides made up ﹤0.01% of Signet Management USA's portfolio in Q4 2013, its #184 holding.
  • 27 funds tracked by Wall St. Rank held NanoViricides as of Q4 2013.

Based on Signet Management USA's 13F filing for Q4 2013, filed 11 Feb 2014.